Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States
Go back to Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States| DR. REDDY'S LAB LTD ADR (NYSE: RDY) | Delayed: 11.97 -0.06 (0.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.03 | 52 Week High | $54.73 | |||
| Open | $12.01 | 52 Week Low | $40.68 | |||
| Day High | $12.06 | P/E | N/A | |||
| Day Low | $11.91 | EPS | $0.00 | |||
| Volume | 2,343,596 | |||||
